Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Age related structural and functional changes in left ventricular performance in healthy subjects: a 2D echocardiographic study.

Vriz O, Pirisi M, Habib E, Galzerano D, Fadel B, Antonini-Canterin F, Veldtman G, Bossone E.

Int J Cardiovasc Imaging. 2019 Jul 11. doi: 10.1007/s10554-019-01665-y. [Epub ahead of print]

PMID:
31297672
2.

Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders.

Bellan M, Giubertoni A, Piccinino C, Dimagli A, Grimoldi F, Sguazzotti M, Burlone ME, Smirne C, Sola D, Marino P, Pirisi M, Sainaghi PP.

Dis Markers. 2019 Jun 2;2019:4981982. doi: 10.1155/2019/4981982. eCollection 2019.

3.

Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma.

Howell J, Atkinson SR, Pinato DJ, Knapp S, Ward C, Minisini R, Burlone ME, Leutner M, Pirisi M, Büttner R, Khan SA, Thursz M, Odenthal M, Sharma R.

Eur J Cancer. 2019 Jul;116:56-66. doi: 10.1016/j.ejca.2019.04.014. Epub 2019 Jun 4.

PMID:
31173963
4.

A 28-Year-Old Woman with Ascites and Multiple Focal Spleen Lesions.

Pirovano A, Matino E, Zecca E, Costanzo M, Croce A, Leutner M, Romito R, Pirisi M.

Eur J Case Rep Intern Med. 2019 May 6;6(5):001061. doi: 10.12890/2019_001061. eCollection 2019.

5.

Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy.

Stroffolini T, Sagnelli E, Sagnelli C, Morisco F, Babudieri S, Furlan C, Pirisi M, Russello M, Smedile A, Pisaturo M, Almasio PL.

Infection. 2019 Apr 26. doi: 10.1007/s15010-019-01308-3. [Epub ahead of print]

PMID:
31028627
6.

Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2).

Peck-Radosavljevic M, Simon K, Iacobellis A, Hassanein T, Kayali Z, Tran A, Makara M, Ben Ari Z, Braun M, Mitrut P, Yang SS, Akdogan M, Pirisi M, Duggal A, Ochiai T, Motomiya T, Kano T, Nagata T, Afdhal N.

Hepatology. 2019 Feb 14. doi: 10.1002/hep.30561. [Epub ahead of print]

PMID:
30762895
7.

First reported human case of meningitis by Staphylococcus condimenti.

Zecca E, Costanzo M, Croce A, Sola D, Pirovano A, Matino E, Pirisi M.

Infection. 2019 Feb 7. doi: 10.1007/s15010-018-01266-2. [Epub ahead of print]

PMID:
30734247
8.

HepaDisk - A new quality of life questionnaire for HCV patients.

Fagiuoli S, Caporaso N, Morisco F, Buelli F, Gualberti G, Saragaglia V, Chessa L, Corti G, Maida I, Mastroianni CM, Pirisi M, Russo FP, Farina F, Giannitrapani L, Toniutto P, Tarquini P, Tundo P, Vecchiet J, Vinci M, Taliani G; HepaDisk Study Group.

Dig Liver Dis. 2019 Jul;51(7):1008-1015. doi: 10.1016/j.dld.2018.12.009. Epub 2018 Dec 23.

9.

Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents.

Gualerzi A, Bellan M, Smirne C, Tran Minh M, Rigamonti C, Burlone ME, Bonometti R, Bianco S, Re A, Favretto S, Bellomo G, Minisini R, Carnevale Schianca GP, Pirisi M.

PLoS One. 2018 Dec 20;13(12):e0209216. doi: 10.1371/journal.pone.0209216. eCollection 2018.

10.

Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis.

Bellan M, Bor S, Gibbin A, Gualerzi A, Favretto S, Guaschino G, Bonometti R, Rossini A, Sola D, Pedrazzoli R, Carnevale Schianca GP, Pirisi M, Sainaghi PP.

Reumatismo. 2018 Dec 20;70(4):232-240. doi: 10.4081/reumatismo.2018.1061.

11.

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.

Merli M, Frigeni M, Alric L, Visco C, Besson C, Mannelli L, Di Rocco A, Ferrari A, Farina L, Pirisi M, Piazza F, Loustaud-Ratti V, Arcari A, Marino D, Sica A, Goldaniga M, Rusconi C, Gentile M, Cencini E, Benanti F, Rumi MG, Ferretti VV, Grossi P, Gotti M, Sciarra R, Tisi MC, Cano I, Zuccaro V, Passamonti F, Arcaini L.

Oncologist. 2018 Dec 14. pii: theoncologist.2018-0331. doi: 10.1634/theoncologist.2018-0331. [Epub ahead of print]

PMID:
30552159
12.

Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy.

Stroffolini T, Sagnelli E, Sagnelli C, Morisco F, Babudieri S, Furlan C, Pirisi M, Russello M, Smedile A, Pisaturo M, Almasio PL.

Can J Gastroenterol Hepatol. 2018 Sep 23;2018:9151820. doi: 10.1155/2018/9151820. eCollection 2018.

13.

Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review.

Bellan M, Castello LM, Pirisi M.

J Clin Transl Hepatol. 2018 Sep 28;6(3):317-325. doi: 10.14218/JCTH.2018.00006. Epub 2018 Jul 2. Review.

14.

The real evidence for polymyalgia rheumatic as a paraneoplastic syndrome.

Bellan M, Sainaghi PP, Pirisi M.

Reumatismo. 2018 Jul 6;70(2):1148. doi: 10.4081/reumatismo.2018.1148.

15.

B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).

Bruzzì S, Sutti S, Giudici G, Burlone ME, Ramavath NN, Toscani A, Bozzola C, Schneider P, Morello E, Parola M, Pirisi M, Albano E.

Free Radic Biol Med. 2018 Aug 20;124:249-259. doi: 10.1016/j.freeradbiomed.2018.06.015. Epub 2018 Jun 18.

16.

Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice.

Bellan M, Menegatti M, Ferrari C, Carnevale Schianca GP, Pirisi M.

Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):610-617. doi: 10.1016/j.numecd.2018.01.006. Epub 2018 Feb 2.

PMID:
29656956
17.

Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma.

Pinato DJ, Pai M, Reccia I, Patel M, Giakoustidis A, Karamanakos G, Rushd A, Jamshaid S, Oldani A, Grossi G, Pirisi M, Tait P, Sharma R.

BMC Cancer. 2018 Feb 20;18(1):211. doi: 10.1186/s12885-018-4120-4.

18.

Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease.

Bellan M, Sainaghi PP, Minh MT, Minisini R, Molinari L, Baldrighi M, Salmi L, Barbaglia MN, Castello LM, Ravanini P, Avanzi GC, Pirisi M.

Biomark Med. 2018 Jan;12(1):27-34. doi: 10.2217/bmm-2017-0171. Epub 2017 Dec 15.

PMID:
29243516
19.

Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study.

Yen C, Sharma R, Rimassa L, Arizumi T, Bettinger D, Choo HY, Pressiani T, Burlone ME, Pirisi M, Giordano L, Abdulrahman A, Kudo M, Thimme R, Park JW, Pinato DJ.

Liver Cancer. 2017 Nov;6(4):313-324. doi: 10.1159/000480441. Epub 2017 Sep 16.

20.

Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.

Sagnelli E, Stroffolini T, Sagnelli C, Pirisi M, Babudieri S, Colloredo G, Russello M, Coppola N, Gaeta GB, Cacopardo B, De Luca M, Almasio PL; EPACRON study group.

Infection. 2018 Feb;46(1):93-101. doi: 10.1007/s15010-017-1101-5. Epub 2017 Nov 17.

PMID:
29150796
21.

Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.

Stroffolini T, Sagnelli E, Andriulli A, Colloredo G, Furlan C, Gaeta GB, Morisco F, Pirisi M, Rosina F, Sagnelli C, Smedile A, Almasio PL; EPACRON study group.

PLoS One. 2017 Nov 15;12(11):e0185710. doi: 10.1371/journal.pone.0185710. eCollection 2017.

22.

Role of Vitamin D in Rheumatoid Arthritis.

Bellan M, Sainaghi PP, Pirisi M.

Adv Exp Med Biol. 2017;996:155-168. doi: 10.1007/978-3-319-56017-5_13. Review.

PMID:
29124698
23.

Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C.

Marconi C, Bellan M, Giarda P, Minisini R, Favretto S, Burlone ME, Franzosi L, Pirisi M.

Ann Gastroenterol. 2017;30(6):675-681. doi: 10.20524/aog.2017.0190. Epub 2017 Sep 6.

24.

Triazolopyridinyl-acrylonitrile derivatives as antimicrotubule agents: Synthesis, in vitro and in silico characterization of antiproliferative activity, inhibition of tubulin polymerization and binding thermodynamics.

Briguglio I, Laurini E, Pirisi MA, Piras S, Corona P, Fermeglia M, Pricl S, Carta A.

Eur J Med Chem. 2017 Dec 1;141:460-472. doi: 10.1016/j.ejmech.2017.09.065. Epub 2017 Oct 3.

PMID:
29055869
25.

Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma.

Fangazio S, Camatta D, Tran Minh M, Ceriani E, Minisini R, Pirisi M.

J Hepatol. 2017 Sep 7. pii: S0168-8278(17)32280-8. doi: 10.1016/j.jhep.2017.06.037. [Epub ahead of print] No abstract available.

PMID:
28890357
26.

Acute decompensated heart failure in the emergency department: Identification of early predictors of outcome.

Castello LM, Molinari L, Renghi A, Peruzzi E, Capponi A, Avanzi GC, Pirisi M.

Medicine (Baltimore). 2017 Jul;96(27):e7401. doi: 10.1097/MD.0000000000007401.

27.

Modulation of Oxidative Stress by 17 β-Estradiol and Genistein in Human Hepatic Cell Lines In Vitro.

Surico D, Ercoli A, Farruggio S, Raina G, Filippini D, Mary D, Minisini R, Surico N, Pirisi M, Grossini E.

Cell Physiol Biochem. 2017;42(3):1051-1062. doi: 10.1159/000478752. Epub 2017 Jun 28.

28.

Etiological factors of chronic hepatitis in Italy: a 2014 national survey.

Stroffolini T, Sagnelli E, Almasio PL, Andriulli A, Smedile A, Pirisi M, Sagnelli C, Russello M, Coppola N, de Luca M, Pisaturo M, Rosina F, Gaeta GB; EPACRON study group.

Eur J Gastroenterol Hepatol. 2017 Sep;29(9):994-997. doi: 10.1097/MEG.0000000000000907.

PMID:
28538268
29.

A case of false positive Troponin I in a patient affected by cryoglobulinemic vasculitis.

Bellan M, Pirisi M, Bellomo G, Sainaghi PP.

Reumatismo. 2017 May 22;69(1):40-42. doi: 10.4081/reumatismo.2017.941.

30.

On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study.

Howell J, Pinato DJ, Ramaswami R, Bettinger D, Arizumi T, Ferrari C, Yen C, Gibbin A, Burlone ME, Guaschino G, Sellers L, Black J, Pirisi M, Kudo M, Thimme R, Park JW, Sharma R.

Aliment Pharmacol Ther. 2017 Apr;45(8):1146-1155. doi: 10.1111/apt.13977. Epub 2017 Mar 2.

31.

Reference values of one-point carotid stiffness parameters determined by carotid echo-tracking and brachial pulse pressure in a large population of healthy subjects.

Vriz O, Aboyans V, Minisini R, Magne J, Bertin N, Pirisi M, Bossone E.

Hypertens Res. 2017 Jul;40(7):685-695. doi: 10.1038/hr.2017.24. Epub 2017 Mar 2.

PMID:
28250412
32.

Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib.

Howell J, Pinato DJ, Ramaswami R, Arizumi T, Ferrari C, Gibbin A, Burlone ME, Guaschino G, Toniutto P, Black J, Sellers L, Kudo M, Pirisi M, Sharma R.

Oncotarget. 2017 May 30;8(22):36161-36170. doi: 10.18632/oncotarget.15322.

33.

Association between rheumatic diseases and cancer: results from a clinical practice cohort study.

Bellan M, Boggio E, Sola D, Gibbin A, Gualerzi A, Favretto S, Guaschino G, Bonometti R, Pedrazzoli R, Pirisi M, Sainaghi PP.

Intern Emerg Med. 2017 Aug;12(5):621-627. doi: 10.1007/s11739-017-1626-8. Epub 2017 Feb 8.

PMID:
28181122
34.

The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug development.

Pinato DJ, Yen C, Bettinger D, Ramaswami R, Arizumi T, Ward C, Pirisi M, Burlone ME, Thimme R, Kudo M, Sharma R.

Aliment Pharmacol Ther. 2017 Mar;45(5):714-722. doi: 10.1111/apt.13904. Epub 2017 Jan 24.

35.

Testosterone Plasma Concentration is Associated with Insulin Resistance in Male Hypertensive Patients.

Schianca GP, Fra GP, Brustia F, Bellan M, Pirovano A, Gualerzi A, Gentile M, Gibbin A, Menegatti M, Bartoli E, Pirisi M.

Exp Clin Endocrinol Diabetes. 2017 Mar;125(3):171-175. doi: 10.1055/s-0042-121492. Epub 2017 Jan 10.

PMID:
28073130
36.

Gas6 as a putative noninvasive biomarker of hepatic fibrosis.

Bellan M, Pogliani G, Marconi C, Minisini R, Franzosi L, Alciato F, Magri A, Avanzi GC, Pirisi M, Sainaghi PP.

Biomark Med. 2016 Dec;10(12):1241-1249. Epub 2016 Dec 7.

PMID:
27924629
37.

17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle.

Magri A, Barbaglia MN, Foglia CZ, Boccato E, Burlone ME, Cole S, Giarda P, Grossini E, Patel AH, Minisini R, Pirisi M.

Liver Int. 2017 May;37(5):669-677. doi: 10.1111/liv.13303. Epub 2016 Nov 25.

38.

Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology.

Stroffolini T, Sagnelli E, Gaeta GB, Sagnelli C, Andriulli A, Brancaccio G, Pirisi M, Colloredo G, Morisco F, Furlan C, Almasio PL; EPACRON study group.

Eur J Intern Med. 2017 Mar;38:68-72. doi: 10.1016/j.ejim.2016.10.012. Epub 2016 Nov 9.

PMID:
27836249
39.

The Gas6/TAM System and Multiple Sclerosis.

Bellan M, Pirisi M, Sainaghi PP.

Int J Mol Sci. 2016 Oct 28;17(11). pii: E1807. Review.

40.

A rare cause of intractable diarrhea.

Gualerzi A, Bellan M, Pirisi M.

Eur J Intern Med. 2017 Mar;38:e6-e7. doi: 10.1016/j.ejim.2016.09.027. Epub 2016 Oct 13. No abstract available.

PMID:
27743913
41.

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.

Pinato DJ, Sharma R, Allara E, Yen C, Arizumi T, Kubota K, Bettinger D, Jang JW, Smirne C, Kim YW, Kudo M, Howell J, Ramaswami R, Burlone ME, Guerra V, Thimme R, Ishizuka M, Stebbing J, Pirisi M, Carr BI.

J Hepatol. 2017 Feb;66(2):338-346. doi: 10.1016/j.jhep.2016.09.008. Epub 2016 Sep 24.

42.

Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.

Sainaghi PP, Bellan M, Lombino F, Alciato F, Carecchio M, Galimberti D, Fenoglio C, Scarpini E, Cantello R, Pirisi M, Comi C.

J Alzheimers Dis. 2017;55(1):59-65.

PMID:
27636849
43.

Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis.

Ramaswami R, Pinato DJ, Kubota K, Ishizuka M, Arizumi T, Kudo M, Jang JW, Kim YW, Pirisi M, Allara E, Sharma R.

Med Oncol. 2016 Oct;33(10):114. doi: 10.1007/s12032-016-0827-8. Epub 2016 Sep 6.

44.

Corrigendum: Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication.

Magri A, Ozerov AA, Tunitskaya VL, Valuev-Elliston VT, Wahid A, Pirisi M, Simmonds P, Ivanov AV, Novikov MS, Patel AH.

Sci Rep. 2016 Aug 25;6:31529. doi: 10.1038/srep31529. No abstract available.

45.

Natural history and risk stratification of patients undergoing non-invasive ventilation in a non-ICU setting for severe COPD exacerbations.

Sainaghi PP, Re A, Bellan M, Navalesi P, Pirisi M.

Intern Emerg Med. 2016 Oct;11(7):1029-30. doi: 10.1007/s11739-016-1516-5. Epub 2016 Aug 2. No abstract available.

PMID:
27485126
46.

Influence of age on sex-related differences among patients with hepatitis C.

Burlone ME, Pedrinelli AR, Giarda P, Minisini R, Pirisi M.

Eur J Gastroenterol Hepatol. 2016 Sep;28(9):1100-1. doi: 10.1097/MEG.0000000000000668. No abstract available.

PMID:
27465347
47.

Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication.

Magri A, Ozerov AA, Tunitskaya VL, Valuev-Elliston VT, Wahid A, Pirisi M, Simmonds P, Ivanov AV, Novikov MS, Patel AH.

Sci Rep. 2016 Jul 12;6:29487. doi: 10.1038/srep29487. Erratum in: Sci Rep. 2016 Aug 25;6:31529.

48.

Profiling the patients visiting the emergency room for musculoskeletal complaints: characteristics and outcomes.

Bellan M, Molinari R, Castello L, Sola D, Gibbin A, Guaschino G, Pedrazzoli R, Puma A, Pirisi M, Avanzi GC, Sainaghi PP.

Clin Rheumatol. 2016 Nov;35(11):2835-2839. Epub 2016 Jun 17.

PMID:
27315242
49.

Natural history and risk stratification of patients undergoing non-invasive ventilation in a non-ICU setting for severe COPD exacerbations.

Sainaghi PP, Colombo D, Re A, Bellan M, Sola D, Balbo PE, Campanini M, Della Corte F, Navalesi P, Pirisi M.

Intern Emerg Med. 2016 Oct;11(7):969-75. doi: 10.1007/s11739-016-1473-z. Epub 2016 Jun 2.

PMID:
27256252
50.

Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study.

Pinato DJ, Arizumi T, Jang JW, Allara E, Suppiah PI, Smirne C, Tait P, Pai M, Grossi G, Kim YW, Pirisi M, Kudo M, Sharma R.

Oncotarget. 2016 Jul 12;7(28):44705-44718. doi: 10.18632/oncotarget.9604.

Supplemental Content

Loading ...
Support Center